Similarly, Thy-1 deficit in an in vivo lung fibrosis mouse model is restored by administrating soluble Thy-1, showing that treatment with soluble Thy-1 therapeutically inhibits integrin-mediated fibrosis (Tan et al., 2019). The gene discussed is THY1; the disease is pulmonary fibrosis.